• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of January 25, 2023

    FDA

    Enforcement Report - Week of September 21, 2022

    FDA

    Enforcement Report - Week of August 24, 2022

    FDA

    Enforcement Report - Week of June 15, 2022

    FDA

    Innocoll Shows Positive Topline Results For XARACOLL implant in Phase 3 Study

    BUSINESSWIRE

    Enforcement Report - Week of August 18, 2021

    FDA

    Enforcement Report- Week of June 9, 2021

    FDA

    Hospira Issues A Voluntary Nationwide Recall for One Lot of 0.5% Bupivacaine Hydrochloride Injection

    FDA

    Enforcement Report - Week of December 30, 2020

    FDA

    Enforcement Report - Week of November 18, 2020

    FDA

    Novel non-opioid postsurgical pain implant launched

    EUROPEANPHARMACEUTICALREVIEW

    Innocoll Announces Commercial Launch of XARACOLL® (bupivacaine HCI)

    PRNEWSWIRE

    Innocoll Holdings Announces FDA Acceptance ofnda for XARACOLL®

    PR NEWSWIRE

    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®

    PR NEWSWIRE

    Innocoll Holdings Resubmits New Drug Application to FDA for XARACOLL®

    PR NEWSWIRE

    Innocoll Holdings Resubmits NDA to FDA for XARACOLL®

    PR NEWSWIRE

    Huons Generic Bupivacaine Hydrochloride Receives Approval in US

    FDA

    Enforcement Report - Week of December 18, 2019

    FDA

    Big Pharma joins £200M UK Biobank sequencing project

    ENDPOINTS NEWS

    Enforcement Report - Week of April 24, 2019

    FDA

    B Braun Medical`s Generic Bupivacaine Hydrochloride Receives Approval in US

    FDA

    Novocol`s Generic Bupivacaine Hydrochloride Receives Approval in US

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Enforcement Report - Week of July 12, 2017

    FDA

    Innocoll Announces Top-Line Data From Phase 3 Trials

    GLOBENEWSWIRE

    Hospira Healthcare Corporation Issues Voluntary Nationwide Recall Of Marcaine 0.50% Due To Defect Possible That Could Compromise The Sealing Plugs

    HEALTHCANADA

    Hospira Issues a Voluntary Nationwide Recall For One Lot Of 0.25% Bupivacaine

    FDA

    Claris Life Gets USFDA Nod For Gneric Anesthetic Injection Bupivacaine

    FDA

    Aurobindo Pharma gets USFDA nod for anesthetic injection

    ECONOMIC TIMES

    Aurobindo`s Generic Bupivacaine HCl approved in US as local anesthetic agent

    FDA

    PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF

    FDA

    DURECT Announces POSIMIR® Program Update

    PR NEWSWIRE

    Apotheca Supply, Inc receives warning letter due to cGMP deviations

    FDA

    US FDA Enforcement report - 16/Mar/2016

    FDA

    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    FIERCE PHARMA MFG

    Drug shortages become issue in Teva and Mylan hook-up

    FIERCE PHARMA MANUFACTURING

    Another Hospira problem, Bupivacaine HCl injection recall.

    FDA

    FDA Drug Shortages: Bupivacaine Hydrochloride (Marcaine, Sensorcaine) Injection

    FDA

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.